Different mutations in the same codon of the proteolipid protein gene,PLP, may help in correlating genotype with phenotype in Pelizaeus-Merzbacher disease/X-linked spastic paraplegia (PMD/SPG2)

Author(s):  
M.E. Hodes ◽  
Andrew W. Zimmerman ◽  
Antonina Aydanian ◽  
Sakkubai Naidu ◽  
Neil R. Miller ◽  
...  
1999 ◽  
Vol 45 (5) ◽  
pp. 624-632 ◽  
Author(s):  
Ken Inoue ◽  
Hitoshi Osaka ◽  
Kiyoshi Imaizumi ◽  
Atsuo Nezu ◽  
Jun-Ichi Takanashi ◽  
...  

1994 ◽  
Vol 6 (3) ◽  
pp. 257-262 ◽  
Author(s):  
Pascale Saugier-Veber ◽  
Arnold Munnich ◽  
Dominique Bonneau ◽  
Jean-Michel Rozet ◽  
Martine Le Merrer ◽  
...  

1993 ◽  
Vol 2 (1) ◽  
pp. 19-22 ◽  
Author(s):  
Akiko Iwaki ◽  
Tamaki Muramoto ◽  
Toru Iwaki ◽  
Hiroyasu Furumi ◽  
Maria L. Dario-deLeon ◽  
...  

2000 ◽  
Vol 99 (1) ◽  
pp. 7-13 ◽  
Author(s):  
A. Sasaki ◽  
K. Miyanaga ◽  
M. Ototsuji ◽  
A. Iwaki ◽  
T. Iwaki ◽  
...  

Author(s):  
Collette Kathleen Hand ◽  
Geneviève Bernard ◽  
Marie-Pierre Dubé ◽  
Michael Israel Shevell ◽  
Guy Armand Rouleau

Objectives:To characterize at clinical and molecular levels a family presenting with X-linked recessive Hereditary Spastic Paraplegia (HSP).Background:HSPs are a large group of genetically heterogeneous neurodegenerative disorders characterized by progressive upper motor neuron signs. Mutations in the proteolipid protein (PLP1) gene have been identified in families linked to the SPG2 locus on chromosome Xq22. However, Pelizaeus-Merzbacher disease (PMD) is also an X-linked recessive neurological disorder caused by PLP1 mutations.Methods:The SPG2 locus was investigated by linkage analysis in the family. The PLP1 gene was screened by sequencing. We present findings in a large French-Canadian family with an X-linked recessive HSP. The proband presented early with developmental delay and developed progressive spastic paraplegia. He has been wheelchair-bound since the age of three years. At the latest follow-up, he was 20 years-old and had severe spasticity predominantly affecting the lower extremities, moderate cerebellar dysfunction, and optic atrophy.Results:Linkage to SPG2 was established and a G to A mutation (M1R) in the initiation codon of the PLP1 gene was identified, likely resulting in the complete absence of proteolipid protein.Conclusion:We report a new PLP1 gene mutation in a patient with a clinical phenotype consistent with a PLP1 null syndrome.


Neurology ◽  
2000 ◽  
Vol 55 (8) ◽  
pp. 1089-1096 ◽  
Author(s):  
G. M. Hobson ◽  
A. P. Davis ◽  
N. C. Stowell ◽  
E. H. Kolodny ◽  
E. A. Sistermans ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document